DHA: DeepView Snapshot Handheld (DV-H) Comparison Study
Study Details
Study Description
Brief Summary
his study is being done to collect pictures of burns using an investigational device called the Spectral MD Deep View Snapshot Handheld (DV-H), similar to a camera. The data collected will be used to assess the performance of the DV-H device, and to determine the device's ability to differentiate healing versus non-healing burn tissue. This device, if approved, is expected to give caregivers a better understanding of what parts of burn wounds will likely not heal on their own and as a tool used by the military in the field. This current study involves the collection of images over the course of your clinical treatment and follow-up according to your routine standard of care. The device will not be used to diagnose or prescribe treatment for your burn
| Condition or Disease | Intervention/Treatment | Phase |
|---|---|---|
|
Study Design
Outcome Measures
Primary Outcome Measures
- DeepView Snapshot Handheld (DV-SSH) Comparison Study Protocol [3 months]
The primary objective of this study is to demonstrate that the proposed SA-MSI sensor is equivalent or better than the current LC-MSI sensor. To conduct this test, we will compare the performance of the burn assessment AI algorithm using the image sensor as input data to the same Algorithm using the lens cluster data as an input.
Eligibility Criteria
Criteria
Inclusion Criteria:
.Age >18 years and able to give informed consent or have a Legally Authorized Representative (LAR) able to do so;
-
Life expectancy > 6 months;
-
Thermal burn mechanism (flame, scald, or contact);
-
The Study Burn(s) occurred less than 72 hours prior to the time of first imaging;
-
Minimum burn wound size for patients is 0.5% TBSA per region
-
Have 2 - 4 regions of their clinical burn(s) that meet the criteria for a Study Burn; and
Exclusion Criteria:
-
Patients will be excluded if any of the following conditions apply:
-
Burn pattern distribution isolated to head, face, neck, hands, feet, genitalia, and/or joints;
-
Subject has burns involving > 50% total body surface area (TBSA);
-
Sepsis at the time of enrollment determined by diagnosis made by Principal Investigator or Sub-Investigator;
-
Immunosuppression/radiation/chemotherapy < 3 months prior to enrollment;
-
Concurrent use of investigational products with a known effect on the burn sites; and/or
-
Any condition that in the opinion of the Investigator may prevent compliance with the study requirements or compromise subject safety.
Contacts and Locations
Locations
| Site | City | State | Country | Postal Code | |
|---|---|---|---|---|---|
| 1 | LSU Health New Orleans University Medical Center New Orleans | New Orleans | Louisiana | United States | 70112 |
Sponsors and Collaborators
- SpectralMD
Investigators
None specified.Study Documents (Full-Text)
None provided.More Information
Publications
None provided.- CLA-PR-01